| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $378K | -36.3% | -77.8% |
| R&D Expense | $19.2M | -5.9% | +7.0% |
| SG&A Expense | $8.4M | -1.0% | -8.8% |
| Operating Income | -$30.2M | +3.9% | -4.4% |
| Pre-tax Income | -$28.6M | +6.0% | -4.5% |
| Income Tax | $104K | -20.6% | +181.1% |
| Net Income | -$28.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.5M | -75.1% | -75.2% |
| Short-term Investments | $143.0M | — | — |
| Accounts Receivable | $1.0M | +42.9% | — |
| Current Assets | $175.0M | +27.4% | +16.6% |
| Total Assets | $245.0M | +16.7% | +4.1% |
| Current Liabilities | $29.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$63.7M | — | — |
| Capital Expenditures | $1.2M | — | — |
| Investing Cash Flow | -$69.7M | — | — |
| Financing Cash Flow | $102.1M | — | — |
| Free Cash Flow | -$65.0M | — | — |
| +6.1% |
| -4.8% |
| EPS (Basic) | -$0.20 | +16.7% | +16.7% |
| EPS (Diluted) | -$0.20 | +16.7% | +16.7% |
| -5.2% |
| +11.3% |
| Total Liabilities | $34.7M | -5.1% | +2.2% |
| Stockholders' Equity | $210.3M | +21.3% | +4.5% |